• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Technology·2465.TW
Share

Leadtek Research Inc. Stocks

NT$ 85.1Last Updated 16.10.2026

Issuer Rating

3/7
Performance

Average

Risk

Moderate

Recommendation

Sell

Market Cap

NT$ 252.32M

NT$ 85.1
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Leadtek Research Inc. engages in design, manufacturing, and trading of communication devices, computers, communications, telecommunications, and peripheral equipment in the United States, Hong Kong, South Korea, Taiwan, Mainland China, and internationally. It operates through two segments: Computer Product Department and Smart Healthcare Department. The company provides virtual desktop systems, including zero and thin client series products, management consoles, and remote workstation cards; graphics cards; professional graphics; AI and high performance computing; AI inference devices; GPU docker management systems and RTX AI software packs; and workstations and servers. It also offers health watches, wearable ECG recorders, fingertip and wearable pulse oximeters, stethoscope recording devices, portable ECG Recorders, biomolecular scanners, ring, deep relief patches, and facial repairing essence; and amor H3 Plus Patch, a non-invasive ECG and audio signal recorder. In addition, the company engages in the provision of after-sales services; software agency, brokerage, trading, and operations; research and development, agency, production, and sales of medical devices and health food; and installation of computer equipment and data processing. The company was founded in 1986 and is headquartered in New Taipei City, Taiwan.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued on

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.10.2026 18:20

BofA expects markets to remain cautious in the coming weeks. What does it recommend doing?

16.10.2026 16:55

Kazakh Gold and Copper: Why Analysts Believe Arras Minerals Shares Will Rise 160%

16.10.2026 16:24

Love and Hate: Experts Name Stocks to Buy on a Pullback. These Aren't Chipmakers

16.10.2026 15:56

Morning in New York: Rotation Supports the Market Amid AI Challenges

16.10.2026 15:10

European stocks are heading toward their widest gap from U.S. stocks since March

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026